MARKER THERAPEUTICS, INC. Deferred Tax Assets, Operating Loss Carryforwards, State and Local
MARKER THERAPEUTICS, INC. (MRKR) had Deferred Tax Assets, Operating Loss Carryforwards, State and Local of $38.60 million as of 2025-12-31, per its 10-K filed 2026-03-18.
Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets › Deferred Tax Assets, Net of Valuation Allowance › Deferred Tax Assets, Gross › Deferred Tax Assets, Operating Loss Carryforwards, Components
us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal · last filed 2026-03-18
- 2025-12-31: Deferred Tax Assets, Operating Loss Carryforwards, State and Local $38.60M.
- 2024-12-31: Deferred Tax Assets, Operating Loss Carryforwards, State and Local $21.90M; Deferred Tax Assets, Operating Loss Carryforwards, State and Local as first filed $38.80M.
- 2023-12-31: Deferred Tax Assets, Operating Loss Carryforwards, State and Local $21.90M; Deferred Tax Assets, Operating Loss Carryforwards, State and Local as first filed $38.40M.
- 2022-12-31: Deferred Tax Assets, Operating Loss Carryforwards, State and Local $21.70M; Deferred Tax Assets, Operating Loss Carryforwards, State and Local as first filed $38.50M.
| Period end | Deferred Tax Assets, Operating Loss Carryforwards, State and Local | Deferred Tax Assets, Operating Loss Carryforwards, State and Local as first filed |
|---|---|---|
| 2025-12-31 | $38.60M 10-K · filed 2026-03-18 | |
| 2024-12-31 | $21.90M 10-K · filed 2026-03-18 | $38.80M 10-K · filed 2025-03-31 |
| 2023-12-31 | $21.90M 10-K · filed 2025-03-31 | $38.40M 10-K · filed 2024-03-26 |
| 2022-12-31 | $21.70M 10-K · filed 2024-03-26 | $38.50M 10-K · filed 2023-03-22 |
| 2021-12-31 | $21.90M 10-K · filed 2023-03-22 | $38.60M 10-K · filed 2022-03-17 |
| 2020-12-31 | $21.90M 10-K · filed 2022-03-17 | $39.00M 10-K · filed 2021-03-09 |
| 2019-12-31 | $21.90M 10-K · filed 2021-03-09 | $47.40M 10-K · filed 2020-03-12 |
| 2018-12-31 | $21.90M 10-K · filed 2020-03-12 | $37.30M 10-K · filed 2019-03-15 |
| 2017-12-31 | $21.80M 10-K · filed 2019-03-15 | $21.90M 10-K · filed 2018-03-23 |
| 2016-12-31 | $11.20M 10-K · filed 2017-03-14 | |
| 2015-12-31 | $4.34M 10-K · filed 2016-04-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |